E Ascari
About
In The Last Decade
E Ascari
163 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 143
- Hematology 1.4k
- Genetics 780
- Molecular Biology 657
- Speech and Hearing 441
- Oncology 397
Countries citing papers authored by E Ascari
This map shows the geographic impact of E Ascari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Ascari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Ascari more than expected).
Fields of papers citing papers by E Ascari
This network shows the impact of papers produced by E Ascari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Ascari. The network helps show where E Ascari may publish in the future.
Co-authorship network of co-authors of E Ascari
This figure shows the co-authorship network connecting the top 25 collaborators of E Ascari. A scholar is included among the top collaborators of E Ascari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Ascari. E Ascari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 18 | |
| 4 | Neighbourhood Quiet Area Definition in the Implementation of European Directive 2002/49/EC | 2 |
| 5 | 13 | |
| 6 | 25 | |
| 7 | 51 | |
| 8 | 13 | |
| 9 | Randomized open study of the dose-effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis | 35 |
| 10 | 19 | |
| 11 | LA P170 NEL MIELOMA MULITIPLO E NELLE LEUCEMIE ACUTE | 2 |
| 12 | EFFETTI SISTEMICI DELLA TERAPIA TROMBOLITICA | 1 |
| 13 | 8 | |
| 14 | 43 | |
| 15 | 10 | |
| 16 | High-dose daunorubicin (DNR) for induction and treatment of relapse in acute promyelocytic leukemia (APL): report of 17 cases. | 1 |
| 17 | 22 | |
| 18 | 4 | |
| 19 | [Diagnostic problems in congenital thrombocytopathies (author's transl)]. | 1 |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.